These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27502248)

  • 1. Radiogenomics to characterize regional genetic heterogeneity in glioblastoma.
    Hu LS; Ning S; Eschbacher JM; Baxter LC; Gaw N; Ranjbar S; Plasencia J; Dueck AC; Peng S; Smith KA; Nakaji P; Karis JP; Quarles CC; Wu T; Loftus JC; Jenkins RB; Sicotte H; Kollmeyer TM; O'Neill BP; Elmquist W; Hoxworth JM; Frakes D; Sarkaria J; Swanson KR; Tran NL; Li J; Mitchell JR
    Neuro Oncol; 2017 Jan; 19(1):128-137. PubMed ID: 27502248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm.
    Wang L; Wang H; D'Angelo F; Curtin L; Sereduk CP; Leon G; Singleton KW; Urcuyo J; Hawkins-Daarud A; Jackson PR; Krishna C; Zimmerman RS; Patra DP; Bendok BR; Smith KA; Nakaji P; Donev K; Baxter LC; Mrugała MM; Ceccarelli M; Iavarone A; Swanson KR; Tran NL; Hu LS; Li J
    PLoS One; 2024; 19(4):e0299267. PubMed ID: 38568950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.
    Gevaert O; Mitchell LA; Achrol AS; Xu J; Echegaray S; Steinberg GK; Cheshier SH; Napel S; Zaharchuk G; Plevritis SK
    Radiology; 2014 Oct; 273(1):168-74. PubMed ID: 24827998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas9 identifies growth-related subtypes of glioblastoma with therapeutical significance through cell line knockdown.
    Zhao N; Weng S; Liu Z; Xu H; Ren Y; Guo C; Liu L; Zhang Z; Ji Y; Han X
    BMC Cancer; 2023 Aug; 23(1):749. PubMed ID: 37580710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective.
    Mathur R; Wang Q; Schupp PG; Nikolic A; Hilz S; Hong C; Grishanina NR; Kwok D; Stevers NO; Jin Q; Youngblood MW; Stasiak LA; Hou Y; Wang J; Yamaguchi TN; Lafontaine M; Shai A; Smirnov IV; Solomon DA; Chang SM; Hervey-Jumper SL; Berger MS; Lupo JM; Okada H; Phillips JJ; Boutros PC; Gallo M; Oldham MC; Yue F; Costello JF
    Cell; 2024 Jan; 187(2):446-463.e16. PubMed ID: 38242087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in
    Makino R; Higa N; Akahane T; Yonezawa H; Uchida H; Takajo T; Fujio S; Kirishima M; Hamada T; Yamahata H; Kamimura K; Yoshiura T; Yoshimoto K; Tanimoto A; Hanaya R
    Neurooncol Adv; 2023; 5(1):vdad110. PubMed ID: 37744696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward Precision Oncology in Glioblastoma with a Personalized Cancer Genome Reporting Tool and Genetic Changes Identified by Whole Exome Sequencing.
    Erdogan O; Özkaya ŞÇ; Erzik C; Bilguvar K; Arga KY; Bayraklı F
    OMICS; 2023 Sep; 27(9):426-433. PubMed ID: 37669106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologically-informed deep neural networks provide quantitative assessment of intratumoral heterogeneity in post-treatment glioblastoma.
    Wang H; Argenziano MG; Yoon H; Boyett D; Save A; Petridis P; Savage W; Jackson P; Hawkins-Daarud A; Tran N; Hu L; Al Dalahmah O; Bruce JN; Grinband J; Swanson KR; Canoll P; Li J
    Res Sq; 2024 Mar; ():. PubMed ID: 38585856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial immunosampling of MRI-defined glioblastoma regions reveals immunologic fingerprint of non-contrast enhancing, infiltrative tumor margins.
    Grabowski MM; Watson DC; Chung K; Lee J; Bayik D; Lauko A; Alban T; Melenhorst JJ; Chan T; Lathia JD; Ahluwalia MS; Mohammadi AM
    medRxiv; 2023 Mar; ():. PubMed ID: 36945620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results.
    Zhou M; Hall L; Goldgof D; Russo R; Balagurunathan Y; Gillies R; Gatenby R
    Transl Oncol; 2014 Feb; 7(1):5-13. PubMed ID: 24772202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric magnetic resonance imaging discerns glioblastoma immune microenvironmental heterogeneity.
    Kersch CN; Muldoon LL; Claunch CJ; Fu R; Schwartz D; Cha S; Starkey J; Neuwelt EA; Barajas RF
    Neuroradiol J; 2023 Jun; ():19714009231163560. PubMed ID: 37306690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiscale quantification of morphological heterogeneity with creation of a predictor of longer survival in glioblastoma.
    Prokop G; Wiestler B; Hieber D; Withake F; Mayer K; Gempt J; Delbridge C; Schmidt-Graf F; Pfarr N; Märkl B; Schlegel J; Liesche-Starnecker F
    Int J Cancer; 2023 Nov; 153(9):1658-1670. PubMed ID: 37501565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualising spatial heterogeneity in glioblastoma using imaging habitats.
    Waqar M; Van Houdt PJ; Hessen E; Li KL; Zhu X; Jackson A; Iqbal M; O'Connor J; Djoukhadar I; van der Heide UA; Coope DJ; Borst GR
    Front Oncol; 2022; 12():1037896. PubMed ID: 36505856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-stage Association Analysis of Glioblastoma Gene Expressions with Texture and Spatial Patterns.
    Elsheikh SSM; Bakas S; Mulder NJ; Chimusa ER; Davatzikos C; Crimi A
    Brainlesion; 2019; 11383():239-250. PubMed ID: 31482151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features.
    Kickingereder P; Bonekamp D; Nowosielski M; Kratz A; Sill M; Burth S; Wick A; Eidel O; Schlemmer HP; Radbruch A; Debus J; Herold-Mende C; Unterberg A; Jones D; Pfister S; Wick W; von Deimling A; Bendszus M; Capper D
    Radiology; 2016 Dec; 281(3):907-918. PubMed ID: 27636026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.
    Sala E; Mema E; Himoto Y; Veeraraghavan H; Brenton JD; Snyder A; Weigelt B; Vargas HA
    Clin Radiol; 2017 Jan; 72(1):3-10. PubMed ID: 27742105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiogenomics: towards a personalized radiation oncology.
    Roberson JD; Burnett OL; Robin N
    Curr Opin Pediatr; 2016 Dec; 28(6):713-717. PubMed ID: 27552070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics in Brain Tumors: An Emerging Technique for Characterization of Tumor Environment.
    Kotrotsou A; Zinn PO; Colen RR
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):719-729. PubMed ID: 27742112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma.
    Liu X; Mangla R; Tian W; Qiu X; Li D; Walter KA; Ekholm S; Johnson MD
    J Neurooncol; 2017 Dec; 135(3):553-560. PubMed ID: 28889246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma.
    Cui Y; Ren S; Tha KK; Wu J; Shirato H; Li R
    Eur Radiol; 2017 Sep; 27(9):3583-3592. PubMed ID: 28168370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.